ClinicalTrials.gov
public full text
Public Domain
Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline
The purpose of this study is to validate \[11C\]ORM-13070 as an alpha2C-adrenoceptor imaging agent for human positron emission tomography (PET) studies of brain alpha2C-adrenoceptor occupancy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Nano-PSO in Parkinson's Disease.#1088740
- [11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)#1127389
- Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies#1008255
- Organ Donor Tissue Oxygen Saturation as a Predictor of Number of Organs to Transplant Per Donor#810997
- A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors#835885
Record · ID 1085545
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive